UN Rejects Calls for Moratorium on Gene Drive Research

Activists claim the technology is too risky, but scientists advise the United Nations to continue to support gene drive research.

By | December 23, 2016

CDC, FRANK HADLEY COLLINS The United Nations (UN) biodiversity meeting, held in Mexico this month, could have ended poorly for scientists working on gene drives, genetic elements that can perpetuate specific mutations and may help cull dangerous mosquito populations. But in spite of environmental activists pushing the UN to ban gene drives, citing the risk of accidental release, the UN’s final agreement—penned December 16—merely urged caution in testing gene drives, Nature reported. Overall, the organization broadly supported further research in synthetic biology.

“I’m very relieved,” Andrea Crisanti, a molecular parasitologist at Imperial College London who works with gene drives, told Nature. “It would have been a disaster for developing the technology.”

By engineering mutations that render organisms infertile or less infectious, then perpetuating these mutations with gene drives, scientists may be able to reduce the occurrence of certain mosquito-born illnesses and cull invasive species. Gene drives have already been tested in yeast, fruit flies, and mosquitoes, and may soon be enlisted in the fight against malaria. One team hopes to conduct field trials in Africa as soon as 2024.

But critics have expressed concern that there is no international framework governing the use of gene drive technology, and some activists had hoped to use the UN meeting in Mexico to encourage a temporary ban on both lab research and field trials until the international community can agree on safeguards. “Right now, given the state of the labs, we shouldn’t do it,” Jaydee Hanson, a policy director at the International Center for Technology Assessment in Washington, DC, who helped organize a coalition of activists pushing for the ban, told Nature.

“Shutting down gene drive technology at this early stage would be a disservice not only to scientific progress but also to the millions of people that gene drives may help in the future,” wrote molecular biologist Julianna LeMieux of the American Council on Science and Health. “Putting a ban on such a powerful technology would be like banning space exploration. Progress involves risk, and shutting down the next step in the process would be a disservice to us all.”  

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham